BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6895301)

  • 21. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases.
    Mulligan AM; O'Malley FP
    Int J Surg Pathol; 2007 Apr; 15(2):143-7. PubMed ID: 17478767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy.
    Leidenius M; Vaalavirta L; Heikkilä P; von Smitten K; Salmenkivi K
    J Surg Oncol; 2008 Jul; 98(1):21-6. PubMed ID: 18484087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine papillary serous carcinoma presenting as distant lymph node metastasis.
    Ng JS; Han AC; Edelson MI; Rosenblum NG
    Gynecol Oncol; 2001 Mar; 80(3):417-20. PubMed ID: 11263944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral axillary metastases of occult breast carcinoma: report of a case with a review of the literature.
    Steunebrink M; Schnater JM; Storm RK; van Ingen G; Vegt PA; Plaisier PW
    Breast; 2005 Apr; 14(2):165-8. PubMed ID: 15767189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymph drainage from the breast to the parasternal lymph nodes].
    Kett K; Szilágyi K; Schmidt L
    Orv Hetil; 1993 Aug; 134(35):1913-5. PubMed ID: 8361746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult axillary lymph node metastases discovered by serial section in node-negative breast cancer.
    Karalak A; Homcha-Em P
    J Med Assoc Thai; 1999 Oct; 82(10):1017-9. PubMed ID: 10561965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry.
    Kainz C; Gitsch G; Lee A; Danihel L; Breitenecker G
    Anticancer Res; 1993; 13(1):73-4. PubMed ID: 7682802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
    Wu WJ; Zeng J; Pan CE
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetries in breast cancer lateralization and both axillary lymph node number and metastatic involvement.
    Dane S; Yildirim S; Koc M; Aktan M; Gundogdu C
    Lymphology; 2008 Jun; 41(2):75-9. PubMed ID: 18720914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
    Laura S; Coombs NJ; Ung O; Boyages J
    ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extraskeletal osteosarcoma in the axilla associated with breast carcinoma.
    Watanabe D; Inoue H; Akiyoshi T
    Eur J Surg Oncol; 1991 Jun; 17(3):319-22. PubMed ID: 1646130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of intraduct appearances in breast cancer.
    Cowen PN; Bates C
    Clin Oncol; 1984 Mar; 10(1):67-72. PubMed ID: 6323084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-grade mucoepidermoid carcinoma of the breast.
    Patchefsky AS; Frauenhoffer CM; Krall RA; Cooper HS
    Arch Pathol Lab Med; 1979 Apr; 103(4):196-8. PubMed ID: 218522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.